Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SKAN Group AGFRA:7VG +2.46%66 Equity-to-Asset is 0.24 as of Dec. 2025, which is 44% below its 10-year median of 0.43. GuruFocus rates FRA:7VG with a GF Score™ of 66/100 and a GF Value™ of €92.07 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 853 Medical Devices & Instruments companies, SKAN Group AG ranks worse than 86.87% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. SKAN Group AG's Total Stockholders Equity for the quarter that ended in Dec. 2025 was €122.7 Mil. SKAN Group AG's Total Assets for the quarter that ended in Dec. 2025 was €515.5 Mil.
Therefore, SKAN Group AG's Equity to Asset Ratio for the quarter that ended in Dec. 2025 was 0.24.
The historical rank and industry rank for SKAN Group AG's Equity-to-Asset or its related term are showing as below:
FRA:7VG'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.16 Med: 0.43 Max: 0.51
Current: 0.24
During the past 6 years, the highest Equity to Asset Ratio of SKAN Group AG was 0.51. The lowest was 0.16. And the median was 0.43.
FRA:7VG's Equity-to-Asset is ranked worse than 86.87% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs FRA:7VG: 0.24
SKAN Group AG (FRA:7VG) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
SKAN Group AG Equity-to-Asset Related Terms
SKAN Group AG Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for SKAN Group AG's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:7VG vs ISRG, BDX, MDLN: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, SKAN Group AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SKAN Group AG Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where SKAN Group AG's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
SKAN Group AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SKAN Group AG (FRA:7VG) has a Equity-to-Asset of 0.24 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on SKAN Group AG and its competitors. This is 44% below median its historical median of 0.43. Over the past decade, SKAN Group AG's Equity-to-Asset has ranged from 0.16 to 0.51. According to the industry distribution chart, SKAN Group AG ranks #741 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 86.9%.
Is SKAN Group AG's Equity-to-Asset too high?
SKAN Group AG's current Equity-to-Asset of 0.24 is 44% below median its 10-year median of 0.43. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 0.51. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. SKAN Group AG's value of 0.24 is 62.5% below this industry median. Based on the distribution chart, SKAN Group AG ranks #741 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SKAN Group AG has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's Equity-to-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SKAN Group AG ranks #741 out of 853 companies for Equity-to-Asset. This places SKAN Group AG in the lower half of its industry. The industry median Equity-to-Asset is 0.64. SKAN Group AG's value of 0.24 is 62.5% below this benchmark. Historically, SKAN Group AG's own Equity-to-Asset has ranged from 0.16 to 0.51 over the past decade. While the company's 10-year median is 0.43 vs. the industry median of 0.64, SKAN Group AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SKAN Group AG's current Equity-to-Asset of 0.24 is 62.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on SKAN Group AG and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SKAN Group AG's current Equity-to-Asset is 0.24, which is 44% below median its own 10-year median of 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (FRA:7VG) is currently considered Significantly Undervalued. The stock's GF Value™ is €92.07, compared to a current price of €62.50 — trading 32.1% below its estimated fair value. The current Equity-to-Asset is 0.24, which is 44% below median its 10-year median of 0.43 and 62.5% below the Medical Devices & Instruments industry median of 0.64. SKAN Group AG's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For SKAN Group AG (FRA:7VG), the current Equity-to-Asset is 0.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SKAN Group AG (FRA:7VG) Overvalued in 2026?
Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued.
The current stock price of €62.50 is trading 32.1% below its estimated GF Value™ of €92.07.
GuruFocus considers SKAN Group AG to be Significantly Undervalued.
Key valuation signals for FRA:7VG:
Equity-to-Asset: 0.24 (44% below median its 10-year median of 0.43)
GF Value™: €92.07 vs. price of €62.50 (32.1% below fair value)
Industry Position: 62.5% below the Medical Devices & Instruments median (#741 of 853)
No single metric tells the full story. See the FRA:7VG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
66GF Score
Get the complete analysis for FRA:7VG
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7VG has been successfully added to your 
